Vlad Coric, M.D.

Vlad Coric, M.D.

Chief Executive OfficeratBiohaven· In proxies 2022–2025

Pay in FY2025+29% from the year before

Vlad Coric, M.D. was paid $13.5M in FY2025 (Dec), up 29%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Biohaven proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BiohavenPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrNo stock prices for these years
  2. Veradermics, Inc.Public company · Less than 1 yr
    • Director2026 – Present · Less than 1 yrNo stock prices for these years
  3. Social Capital Suvretta Holdings CorpPublic company
    • Director? – PresentNo stock prices for these years
  4. Revance Therapeutics, Inc.Public company · 2 yr
    • Director2023 – 2025 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?